Amarin Corporation plc (AMRN)
Cantor Virtual Global Healthcare Conference Call
September 16, 2020 11:20 A.M. ET
Company Participants
John Thero - Chief Executive Officer
Conference Call Participants
Louise Chen - Cantor Fitzgerald
Presentation
Louise Chen
Hi, I'm Louise Chen, the large cap and biopharma analyst here at Cantor. Thank you for joining us today for our virtual fireside chat with Amarin. Amarin launched VASCEPA in first quarter of 2020 in the U.S. as the first and only FDA approved drug to reduce persistent cardiovascular risk beyond stem therapy in studied patients. We think the peak